Li Suiyan

Li Suiyan


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2022 in Chinese Journal of Traumatology
Verified
Journal Article
Open access
KLKe Liu
Ke Liu
JYJing Yu
Jing Yu
YXYu Xia
Yu Xia
LZLei-Ting Zhang
Lei-Ting Zhang
LSLi Suiyan
Li Suiyan
JYJun Yan
Jun Yan
The combined use of antibiotics and anti-inflammatory medicine to manage bacterial endotoxin-induced inflammation following injuries or diseases is increasing. The cytokine level produced by macrophages plays an important role in this treatment course. Ciprofloxacin and indomethacin, two typical representatives of antibiotics and anti-inflammatory medicine, are cost-effective and has been reported to show satisfactory effect. The current study aims to investigate the effect of ciprofloxacin along with indomethacin on the secretion of inflammatory cytokines by macrophages in vitro. Primary murine peritoneal macrophages and RAW 264.7 cells were administrated with lipopolysaccharide (LPS) for 24 h. The related optimal dose and time point of ciprofloxacin or indomethacin in response to macrophage inflammatory response inflammation were determined via macrophage secretion induced by LPS. Then, the effects of ciprofloxacin and indomethacin on the secretory functions and viability of various macrophages were determined by enzyme-linked immunosorbent assay and flow cytometry analysis, especially for the levels of interleukin (IL)-1β, IL-6, IL-10, and tumor necrosis factor (TNF)-α. The optimal dose and time course of ciprofloxacin affecting macrophage inflammatory response were determined by testing the maximum inhibitory effect of the drugs on pro-inflammatory factors at each concentration or time point. According to the levels of cytokines secreted by various macrophages (1.2 × 106 cells/well) after administration of 1 μg/mL LPS, the optimal dose and usage timing for ciprofloxacin alone were 80 μg/mL and 24 h, respectively, and the optimal dose for indomethacin alone was 10 μg/mL. Compared with the LPS-stimulated group, the combination of ciprofloxacin and indomethacin reduced the levels of IL-1β (p < 0.05), IL-6 (p < 0.05), IL-10 (p < 0.01)), and TNF-α (p < 0.01). Furthermore, there was greater stability in the reduction of inflammatory factor levels in the combination group compared with those in which only ciprofloxacin or indomethacin was used. The combination of ciprofloxacin and indomethacin suppressed the levels of inflammatory cytokines secreted by macrophages in vitro. This study illustrates the regulatory mechanism of drug combinations on innate immune cells that cause inflammatory reactions. In addition, it provides a new potential antibacterial and anti-inflammatory treatment pattern to prevent and cure various complications in the future.

1 September 2021
Verified
Journal Article
Closed access
WMWan-Di Ma
Wan-Di Ma
PFPing Fan
Ping Fan
HLHong-Wei Liu
Hong-Wei Liu
QLQing-Qing Liu
Qing-Qing Liu
KHKai-Feng Hu
Kai-Feng Hu
LSLi Suiyan
Li Suiyan

10 June 2025
Verified
Journal Article
Closed access
YGYuwen Guo
Yuwen Guo
HBHuai Bai
Huai Bai
LGLinbo Guan
Linbo Guan
XLXinghui Liu
Xinghui Liu
PFPing Fan
Ping Fan
LSLi Suiyan
Li Suiyan

10 July 2024
Verified
Journal Article
Closed access
XZXinyuan Zhang
Xinyuan Zhang
PFPing Fan
Ping Fan
QLQingqing Liu
Qingqing Liu
XLXinghui Liu
Xinghui Liu
HBHuai Bai
Huai Bai
LSLi Suiyan
Li Suiyan

10 July 2020
Verified
Journal Article
Closed access
YSYuan Sun
Yuan Sun
PFPing Fan
Ping Fan
QLQingqing Liu
Qingqing Liu
HBHuai Bai
Huai Bai
XLXinghui Liu
Xinghui Liu
LSLi Suiyan
Li Suiyan